These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2879528)

  • 1. Characterisation and quantitation of pilus antigens of Moraxella bovis by ELISA.
    Lepper AW; Hermans LR
    Aust Vet J; 1986 Dec; 63(12):401-5. PubMed ID: 2879528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic cross-reactivity of Australian Moraxella bovis to vaccinal bacterin strains as determined by competitive ELISA.
    McConnel CS; Shum L; Gleeson BL; House JK
    Aust Vet J; 2008 Apr; 86(4):124-9. PubMed ID: 18363984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic analysis of fimbrial proteins from Moraxella bovis.
    Moore LJ; Rutter JM
    J Clin Microbiol; 1987 Nov; 25(11):2063-70. PubMed ID: 2891723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity and immunogenicity of piliated and nonpiliated phases of Moraxella bovis in calves.
    Jayappa HG; Lehr C
    Am J Vet Res; 1986 Oct; 47(10):2217-21. PubMed ID: 2877604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic and protective characterization of Moraxella bovis pili.
    Lehr C; Jayappa HG; Goodnow RA
    Cornell Vet; 1985 Oct; 75(4):484-92. PubMed ID: 2865080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious bovine keratoconjunctivitis epizootic associated with area-wide emergence of a new Moraxella bovis pilus type.
    Vandergaast N; Rosenbusch RF
    Am J Vet Res; 1989 Sep; 50(9):1437-41. PubMed ID: 2572190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-bacterial cell enzyme-linked immunosorbent assay for cell-bound Moraxella bovis pili.
    Prieto CI; Rodriguez ME; Bosch A; Chirdo FG; Yantorno OM
    Vet Microbiol; 2003 Feb; 91(2-3):157-68. PubMed ID: 12458165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective efficacy of pili from different strains of Moraxella bovis within the same serogroup against infectious bovine keratoconjunctivitis.
    Lepper AW; Moore LJ; Atwell JL; Tennent JM
    Vet Microbiol; 1992 Sep; 32(2):177-87. PubMed ID: 1359693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectivity and virulence of Australian strains of Moraxella bovis for the murine and bovine eye in relation to pilus serogroup sub-unit size and degree of piliation.
    Lepper AW; Power BE
    Aust Vet J; 1988 Oct; 65(10):305-9. PubMed ID: 2904256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK).
    Lepper AW; Atwell JL; Lehrbach PR; Schwartzkoff CL; Egerton JR; Tennent JM
    Vet Microbiol; 1995 Jul; 45(2-3):129-38. PubMed ID: 7571364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against infectious bovine keratoconjunctivitis: protective efficacy and antibody response induced by pili of homologous and heterologous strains of Moraxella bovis.
    Lepper AW
    Aust Vet J; 1988 Oct; 65(10):310-6. PubMed ID: 2904257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis pilin-Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Bonifacio RG; Ball LM; Hess JF
    Vet Microbiol; 2007 Dec; 125(3-4):274-83. PubMed ID: 17656049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled field trial to assess efficacy of a Moraxella bovis pilin-cytotoxin-Moraxella bovoculi cytotoxin subunit vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
    Angelos JA; Gohary KG; Ball LM; Hess JF
    Am J Vet Res; 2012 Oct; 73(10):1670-5. PubMed ID: 23013196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic characterization of Moraxella bovis, Moraxella bovoculi and Moraxella ovis strains with potential use in vaccines.
    Kowalski AP; Maboni G; Gressler LT; Espíndola JP; Balzan C; Tasca C; Guizzo JA; Conceição FR; Frandoloso R; de Vargas AC
    Vet Microbiol; 2017 Oct; 210():56-63. PubMed ID: 29103697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unified serotyping scheme for Moraxella bovis.
    Moore LJ; Lepper AW
    Vet Microbiol; 1991 Sep; 29(1):75-83. PubMed ID: 1683047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of a Moraxella bovis bacterin containing attachment and cornea-degrading enzyme antigens.
    Gerber JD; Selzer NL; Sharpee RL; Beckenhauer WH
    Vet Immunol Immunopathol; 1988 Feb; 18(1):41-52. PubMed ID: 3376421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic response of vaccinated cattle to strains of Moraxella bovis isolated during epizootics of keratoconjunctivitis.
    Pugh GW; Hughes DE; Booth GD
    Am J Vet Res; 1978 Jan; 39(1):55-7. PubMed ID: 415645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection rates, disease frequency, pilin gene rearrangement, and pilin expression in calves inoculated with Moraxella bovis pilin-specific isogenic variants.
    Ruehl WW; Marrs CF; George L; Banks SJ; Schoolnik GK
    Am J Vet Res; 1993 Feb; 54(2):248-53. PubMed ID: 8094276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine against infectious bovine keratoconjunctivitis: a new approach to optimize the production of highly piliated Moraxella bovis cells.
    Prieto CI; Bosch A; Zielinski G; Cúneo J; Yantorno OM
    Vaccine; 2008 Dec; 26(51):6542-9. PubMed ID: 18852003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outer membrane protein antigens of Moraxella bovis.
    Ostle AG; Rosenbusch RF
    Am J Vet Res; 1986 Jul; 47(7):1419-21. PubMed ID: 3740610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.